Late-stage pharmaceutical R&D and pricing policies under two-stage regulation
Sebastian Jobjörnsson, Martin Forster, Paolo Pertile, Carl-Fredrik Burman
| Year of publication: |
December 2016
|
|---|---|
| Authors: | Jobjörnsson, Sebastian ; Forster, Martin ; Pertile, Paolo ; Burman, Carl-Fredrik |
| Published in: |
Journal of health economics. - Amsterdam [u.a.] : Elsevier, ISSN 0167-6296, ZDB-ID 625797-5. - Vol. 50.2016, p. 298-311
|
| Subject: | Pharmaceutical pricing and reimbursement | Rare diseases | Optimal sample size | Static and dynamic efficiency | Cost-effectiveness threshold | Arzneimittel | Pharmaceuticals | Theorie | Theory | Pharmaindustrie | Pharmaceutical industry | Preisregulierung | Price regulation | Regulierung | Regulation | Arzneimittelmarkt | Pharmaceutical market | Effizienz | Efficiency | Gesundheitskosten | Health care costs |
| Type of publication: | Article |
|---|---|
| Type of publication (narrower categories): | Aufsatz in Zeitschrift ; Article in journal |
| Language: | English |
| Other identifiers: | 10.1016/j.jhealeco.2016.06.002 [DOI] |
| Source: | ECONIS - Online Catalogue of the ZBW |
Persistent link: https://www.econbiz.de/10011589153